139
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Immunoresistance in Cervical Dystonia Patients After Treatment With AbobotulinumtoxinA

, , , , &
Pages 358-362 | Received 13 Oct 2011, Published online: 11 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

O. Abu-hadid & J. Jimenez-Shahed. (2022) An overview of the pharmacotherapeutics for dystonia: advances over the past decade. Expert Opinion on Pharmacotherapy 23:17, pages 1927-1940.
Read now

Articles from other publishers (8)

Eqram Rahman, Hitmi Khalifa Alhitmi & Afshin Mosahebi. (2022) Immunogenicity to Botulinum Toxin Type A: A Systematic Review With Meta-Analysis Across Therapeutic Indications. Aesthetic Surgery Journal 42:1, pages 106-120.
Crossref
Steven Bellows & Joseph Jankovic. (2019) Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 11:9, pages 491.
Crossref
H.A. Jinnah, Cynthia L. Comella, Joel Perlmutter, Codrin Lungu & Mark Hallett. (2018) Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?. Toxicon 147, pages 89-95.
Crossref
Sebastien Lacroix-Desmazes, Stephane Mouly, Michel-Robert Popoff & Carlo Colosimo. (2017) Systematic analysis of botulinum neurotoxin type A immunogenicity in clinical studies. Basal Ganglia 9, pages 12-17.
Crossref
H. A. Jinnah, Emily Goodmann, Ami R. Rosen, Marian Evatt, Alan Freeman & Stewart Factor. (2016) Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes. Journal of Neurology 263:6, pages 1188-1194.
Crossref
Joaquim J. Ferreira, Carlo Colosimo, Roongroj Bhidayasiri, Maria Jose Marti, Pascal Maisonobe & Savary Om. (2015) Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia. Parkinsonism & Related Disorders 21:2, pages 111-115.
Crossref
Josef Finsterer & Gonzalo J. Revuelta. (2014) Anterocollis and anterocaput. Clinical Neurology and Neurosurgery 127, pages 44-53.
Crossref
Jack J. ChenKhashayar Dashtipour. (2013) Abo‐, Inco‐, Ona‐, and Rima‐Botulinum Toxins in Clinical Therapy: A Primer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33:3, pages 304-318.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.